The store will not work correctly when cookies are disabled.
3-(2,5-dichlorophenylsulfonamido)-4-(dimethylamino)-N,N-dimethylbenzenesulfonamide
ID: ALA4540200
PubChem CID: 17543415
Max Phase: Preclinical
Molecular Formula: C16H19Cl2N3O4S2
Molecular Weight: 452.39
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CN(C)c1ccc(S(=O)(=O)N(C)C)cc1NS(=O)(=O)c1cc(Cl)ccc1Cl
Standard InChI: InChI=1S/C16H19Cl2N3O4S2/c1-20(2)15-8-6-12(27(24,25)21(3)4)10-14(15)19-26(22,23)16-9-11(17)5-7-13(16)18/h5-10,19H,1-4H3
Standard InChI Key: OHHFTDDNZMQYKA-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 28 0 0 0 0 0 0 0 0999 V2000
9.0180 -9.6330 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.8352 -9.6330 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
9.4266 -8.9252 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.5439 -10.9660 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.9566 -11.6759 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
12.3650 -10.9636 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.6650 -12.0845 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6639 -12.9040 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3719 -13.3130 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0816 -12.9036 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0788 -12.0809 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3702 -11.6756 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2496 -12.0848 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.5416 -11.6768 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5444 -10.8594 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8372 -10.4514 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1288 -10.8606 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1321 -11.6820 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8399 -12.0863 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3677 -10.8584 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
13.3717 -14.1302 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
9.8436 -12.9035 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.1378 -13.3154 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5532 -13.3088 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5445 -9.2254 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.5443 -8.4082 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2524 -9.6338 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
5 4 2 0
6 5 2 0
7 8 2 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 7 1 0
7 5 1 0
5 13 1 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 14 1 0
12 20 1 0
9 21 1 0
19 22 1 0
22 23 1 0
22 24 1 0
16 2 1 0
2 25 1 0
25 26 1 0
25 27 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 452.39 | Molecular Weight (Monoisotopic): 451.0194 | AlogP: 3.11 | #Rotatable Bonds: 6 |
Polar Surface Area: 86.79 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 7 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 6.73 | CX Basic pKa: 1.15 | CX LogP: 2.83 | CX LogD: 2.26 |
Aromatic Rings: 2 | Heavy Atoms: 27 | QED Weighted: 0.73 | Np Likeness Score: -2.31 |
References
1. Follows B, Fessler S, Baumeister T, Campbell AM, Zablocki MM, Li H, Gotur D, Wang Z, Zheng X, Molz L, Nguyen C, Herbertz T, Wang L, Bair K.. (2019) Discovery of novel biaryl sulfonamide based Mcl-1 inhibitors., 29 (16): [PMID:31235261] [10.1016/j.bmcl.2019.06.008] |